HealthStream (NASDAQ:HSTM) Price Target Raised to $27.00

HealthStream (NASDAQ:HSTM) had its price objective hoisted by Canaccord Genuity Group from $24.00 to $27.00 in a report issued on Tuesday, Marketbeat.com reports. They currently have a hold rating on the technology company’s stock.

Several other analysts also recently commented on HSTM. Weiss Ratings raised shares of HealthStream from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, June 23rd. Wall Street Zen upgraded shares of HealthStream from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Three analysts have rated the stock with a Hold rating, Based on data from MarketBeat, HealthStream presently has an average rating of “Hold” and an average target price of $27.00.

HealthStream Price Performance

Shares of NASDAQ HSTM opened at $26.39 on Tuesday. The business’s 50-day moving average price is $26.25 and its two-hundred day moving average price is $23.08. HealthStream has a one year low of $19.50 and a one year high of $30.00. The company has a market capitalization of $771.12 million, a P/E ratio of 39.39, a price-to-earnings-growth ratio of 3.05 and a beta of 0.45.

HealthStream (NASDAQ:HSTM) last announced its quarterly earnings results on Monday, May 4th. The technology company reported $0.20 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.16 by $0.04. HealthStream had a return on equity of 6.47% and a net margin of 6.39%.The business had revenue of $81.20 million during the quarter, compared to analyst estimates of $79.68 million. On average, equities analysts anticipate that HealthStream will post 0.74 EPS for the current year.

HealthStream Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, May 29th. Shareholders of record on Monday, May 18th were given a dividend of $0.035 per share. The ex-dividend date of this dividend was Monday, May 18th. This represents a $0.14 dividend on an annualized basis and a yield of 0.5%. HealthStream’s dividend payout ratio is presently 20.90%.

Insider Buying and Selling

In other news, Director Linda Rebrovick sold 6,000 shares of the business’s stock in a transaction on Monday, July 6th. The shares were sold at an average price of $29.00, for a total value of $174,000.00. Following the completion of the sale, the director directly owned 51,329 shares in the company, valued at approximately $1,488,541. The trade was a 10.47% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Kevin P. O’hara sold 3,000 shares of the company’s stock in a transaction on Wednesday, May 20th. The stock was sold at an average price of $24.08, for a total transaction of $72,240.00. Following the sale, the executive vice president directly owned 20,982 shares of the company’s stock, valued at approximately $505,246.56. This represents a 12.51% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 11,000 shares of company stock worth $296,240. Insiders own 20.40% of the company’s stock.

Institutional Investors Weigh In On HealthStream

Hedge funds have recently bought and sold shares of the company. Dimensional Fund Advisors LP increased its position in HealthStream by 6.4% during the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock worth $30,156,000 after acquiring an additional 87,177 shares during the period. Copeland Capital Management LLC boosted its holdings in HealthStream by 43.8% in the 1st quarter. Copeland Capital Management LLC now owns 1,276,739 shares of the technology company’s stock valued at $26,441,000 after purchasing an additional 389,186 shares during the period. Renaissance Technologies LLC grew its position in HealthStream by 0.5% in the 1st quarter. Renaissance Technologies LLC now owns 477,848 shares of the technology company’s stock worth $9,896,000 after purchasing an additional 2,380 shares during the last quarter. JPMorgan Chase & Co. grew its position in HealthStream by 4.6% in the 4th quarter. JPMorgan Chase & Co. now owns 452,897 shares of the technology company’s stock worth $10,448,000 after purchasing an additional 20,075 shares during the last quarter. Finally, First Eagle Investment Management LLC increased its holdings in shares of HealthStream by 1.1% during the 4th quarter. First Eagle Investment Management LLC now owns 413,698 shares of the technology company’s stock worth $9,544,000 after purchasing an additional 4,300 shares during the period. 69.58% of the stock is currently owned by institutional investors.

About HealthStream

HealthStream, Inc is a Nashville, Tennessee–based provider of workforce development and learning management solutions for healthcare organizations. Since its founding in 1990, the company has focused on helping hospitals, clinics and other care providers streamline staff training, ensure regulatory compliance and monitor employee performance. HealthStream’s platform integrates online courses, skill competency assessments and credential management tools to support workforce readiness across the healthcare continuum.

The company’s core offerings include a learning management system (LMS) designed specifically for clinical and nonclinical personnel, a competency management suite that tracks skill acquisition and validation, and a content library featuring evidence-based clinical and compliance training modules.